2010-2019年美国远处转移期癌症患者早期姑息治疗计费的趋势及提供者与组织层面相关因素
基于SEER-Medicare数据,2010-2019年102,032例远处转移期癌症患者中,早期姑息治疗计费比例从1.44%升至10.36%(P<.001)。治疗医生既往早期姑息治疗转诊及机构雇用HPM专家与更高计费可能性相关,提供者间差异从51.0%降至45.3%。
要点
- 2010-2019年早期姑息治疗计费比例从1.44%升至10.36%(P<.001),但整体水平仍低。
- 医生既往早期姑息治疗转诊与计费可能性高3.01个百分点(95%CI 2.50-3.52)相关。
- 机构雇用HPM专家与计费可能性高4.54个百分点(95%CI 3.65-5.42)相关。
核心结论
- 尽管2010-2019年远处转移期癌症患者早期姑息治疗计费有所增长,但其水平仍低。
- 提供者特征如转诊模式和机构内HPM专家可用性可能是早期姑息治疗利用的重要驱动因素。
研究设计与样本
- 使用SEER-Medicare数据,纳入2010-2019年确诊的远处转移期女性乳腺癌、结直肠癌、非小细胞肺癌、小细胞肺癌、胰腺癌或前列腺癌的65.5岁及以上Medicare按服务收费受益人,要求生存≥6个月。
- 早期姑息治疗计费通过癌症诊断后前3个月内或至临终关怀入院日(以先到者为准)的门诊索赔中的诊断代码或临终关怀与姑息医学(HPM)专业代码识别。
- 采用多变量回归分析提供者和组织层面因素与早期姑息治疗计费的相关性及提供者间和组织间变异。
主要发现
- 在102,032例患者(由18,908名 unique 医生治疗)中,早期姑息治疗计费百分比从2010年的1.44%增至2019年的10.36%(P<.001)。
- 治疗医生前一年早期姑息治疗转诊与早期姑息治疗计费可能性高3.01个百分点(95%CI 2.50-3.52)相关。
- 机构雇用任何HPM专家与早期姑息治疗计费可能性高4.54个百分点(95%CI 3.65-5.42)相关。
- 提供者间早期姑息治疗变异从2010-2013年的51.0%降至2017-2019年的45.3%。
- 组织间变异呈现相似模式。
关键数值与推荐
- 早期姑息治疗计费定义为癌症诊断后前3个月内或至临终关怀入院日(以先到者为准)的门诊索赔中出现诊断代码或HPM专业代码。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Early integration of specialized palliative care (PC) is recommended by clinical guidelines for advanced-stage cancers, but real-world evidence of its use is limited. We examined the recent trend of early PC billing among Medicare beneficiaries with distant-stage cancers and associated provider- and organization-level factors. METHODS: Using SEER-Medicare data, we identified Medicare Fee-For-Service beneficiaries 65.5 years and older diagnosed with distant-stage female breast, colorectal, non-small cell lung, small cell lung, pancreatic, or prostate cancers in 2010-2019 with a survival of ≥6 months. Early PC billing was identified by diagnosis codes or hospice and palliative medicine (HPM) specialty codes on outpatient claims within first 3 months of cancer diagnosis or up to hospice admission date, whichever came first. Annual percentages of patients receiving early PC were assessed. We attributed treating physicians and organizations to patients and identified provider- and organization-level factors associated with early PC billing and the between-provider and between-organization variation in early PC billing using multivariable regressions. RESULTS: Among 102,032 patients treated by 18,908 unique physicians, the percentage with early PC billing increased from 1.44% to 10.36% in 2010-2019 (P < .001). Treating physician's early PC referrals in the previous year and organizations' employment of any HPM specialist were associated with 3.01 percentage points (ppts, 95% CI, 2.50 to 3.52) and 4.54 ppts (95% CI, 3.65 to 5.42) higher likelihood of early PC billing. Between-provider variation in early PC was considerable but declined from 51.0% in 2010-2013 to 45.3% in 2017-2019. Similar patterns were found for between-organization variation. CONCLUSION: Despite growth in early PC billing among patients with distant-stage cancers in 2010-2019, its level remained low. Provider and organizational characteristics such as referral patterns and availability of HPM specialists within the organization may be important drivers for early PC utilization.
引用
- Hu X, Kwon Y, Jiang C, et al. Trend and Provider- and Organizational-Level Factors Associated With Early Palliative Care Billing Among Patients Diagnosed With Distant-Stage Cancers in 2010-2019 in the United States. J Clin Oncol. 2025. PMID: 40053887. doi:10.1200/JCO-24-01935
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。